Hello all, attaching a link to a decent layman's article on the history of Fragile X hopes and fears in the USA. ACW not mentioned . but a past investigation onto Alzheimer drugs and FX are... for whats it's worth...
""In 2015, Mark Gurney was running a small biotech with a drug aimed at treating Alzheimer’s when he came across a Fragile X scientific paper, co-authored by Tranfaglia.Gurney wondered if the same brain circuit his Alzheimer’s drug addressed might also help target the malfunctions in Fragile X.The only way to find out was to first test the drug in animals.
But Gurney’s eight-person company, Tetra Pharmaceuticals, didn't have access to mice with the Fragile X mutation. So FRAXA, working with a lab in Chile, ran them."It was a critically important contribution," Gurney said. "We may not have considered Fragile X otherwise."Results looked extremely promising. Mice with the same genetic mutation as people with Fragile X who got the drug were no longer hyperactive.
They became more sociable and started nest-making. The longer the mice got the drug, the more they improved.
